» Articles » PMID: 27725627

Prophylactic Administration of Silybin Ameliorates L-Arginine-Induced Acute Pancreatitis

Overview
Journal Med Sci Monit
Date 2016 Oct 12
PMID 27725627
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Oxidative stress have been shown to play a role in the pathogenesis of acute pancreatitis. The aim of this study was to investigate the potential effect of silybin, a potent antioxidant, on L-arginine-induced acute pancreatitis in an experimental rat model. MATERIAL AND METHODS Forty female Wistar Albino rats were divided into 5 groups as follows: Group 1 (C): control group (n=8), Group 2 (SL): silybin group (n=8), Group 3 (LA): acute pancreatitis group (n=8), Group 4 (SLLA): prophylaxis group (n=8), and Group 5 (LASL): treatment group (n=8). Group C (control) received 2 intraperitoneal (i.p.) injections of physiological saline at an interval of 1 h. Group SL received only a single i.p. injection of silybin. The SLLA group received a single i.p. injection of silybin before the induction of acute pancreatitis with L-arginine, whereas the LASL group received the same injection after the induction of acute pancreatitis with L-arginine. Pancreatic tissues were histopathologically examined. Levels of amylase and oxidative stress markers (total oxidant status and total anti-oxidant status) were determined in the blood samples. Oxidative stress index was calculated. RESULTS In comparison to the LA, the prophylaxis and treatment groups showed significant improvements in serum oxidative stress parameters (p=0.001 and p=0.005, respectively). Histopathological analysis showed that the treatment group had significant improvements in edema scores only (p=0.006), whereas the prophylaxis group had the same improvements in inflammation and necrosis scores as well as in total scores (p=0.004, 0.006, and 0.004, respectively). CONCLUSIONS When used for prophylactic rather than therapeutic purposes, silybin ameliorates serum oxidative stress parameters and improves histopathological results via its antioxidant and anti-inflammatory properties.

Citing Articles

Silymarin and Inflammation: Food for Thoughts.

Surai P, Surai A, Earle-Payne K Antioxidants (Basel). 2024; 13(1).

PMID: 38247522 PMC: 10812610. DOI: 10.3390/antiox13010098.


Ferulic acid attenuates pancreaticobiliary duct occlusion-induced inflammation in both pancreas and liver.

Cilingir S, Acikel-Elmas M, Arbak S, Kolgazi M Inflammopharmacology. 2023; 31(2):997-1008.

PMID: 36752934 DOI: 10.1007/s10787-023-01150-y.


Murine Models of Acute Pancreatitis: A Critical Appraisal of Clinical Relevance.

Silva-Vaz P, Abrantes A, Castelo-Branco M, Gouveia A, Botelho M, Tralhao J Int J Mol Sci. 2019; 20(11).

PMID: 31181644 PMC: 6600324. DOI: 10.3390/ijms20112794.

References
1.
Elmunzer B, Waljee A, Elta G, Taylor J, Fehmi S, Higgins P . A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008; 57(9):1262-7. DOI: 10.1136/gut.2007.140756. View

2.
Mitchell R, Byrne M, Baillie J . Pancreatitis. Lancet. 2003; 361(9367):1447-55. DOI: 10.1016/s0140-6736(03)13139-x. View

3.
Trouillas P, Marsal P, Svobodova A, Vostalova J, Gazak R, Hrbac J . Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study. J Phys Chem A. 2008; 112(5):1054-63. DOI: 10.1021/jp075814h. View

4.
Robles L, Vaziri N, Ichii H . Role of Oxidative Stress in the Pathogenesis of Pancreatitis: Effect of Antioxidant Therapy. Pancreat Disord Ther. 2014; 3(1):112. PMC: 4009983. DOI: 10.4172/2165-7092.1000112. View

5.
Letteron P, Labbe G, Degott C, Berson A, Fromenty B, Delaforge M . Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem Pharmacol. 1990; 39(12):2027-34. DOI: 10.1016/0006-2952(90)90625-u. View